AAAAAA
Results: 1-25/31
Authors:
Inden, Y
Hirai, M
Takada, Y
Shimizu, A
Shimokata, K
Yoshida, Y
Akahoshi, M
Kondo, T
Saito, H
Citation: Y. Inden et al., Prolongation of activation-recovery interval over a preexcited region before and after catheter ablation in patients with Wolff-Parkinson-White syndrome, J CARD ELEC, 12(8), 2001, pp. 939-945
Authors:
Ando, M
Ando, Y
Hasegawa, Y
Sekido, Y
Shimokata, K
Horibe, K
Citation: M. Ando et al., Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia, PHARMACOGEN, 11(3), 2001, pp. 269-273
Authors:
Shigemitsu, K
Sekido, Y
Usami, N
Mori, S
Sato, M
Horio, Y
Hasegawa, Y
Bader, SA
Gazdar, AF
Minna, JD
Hida, T
Yoshioka, H
Imaizumi, M
Ueda, Y
Takahashi, M
Shimokata, K
Citation: K. Shigemitsu et al., Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion, ONCOGENE, 20(31), 2001, pp. 4249-4257
Authors:
Noguchi, M
Imaizumi, K
Kawabe, T
Wakayama, H
Horio, Y
Sekido, Y
Hara, T
Hashimoto, N
Takahashi, M
Shimokata, K
Hasegawa, Y
Citation: M. Noguchi et al., Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer, CANC GENE T, 8(6), 2001, pp. 421-429
Authors:
Aoshima, T
Kajita, T
Sekido, Y
Mimura, S
Itakura, A
Yasuda, I
Saheki, T
Watanabe, K
Shimokata, K
Niwa, T
Citation: T. Aoshima et al., Carbamoyl phosphate synthetase I deficiency: molecular genetic findings and prenatal diagnosis, PRENAT DIAG, 21(8), 2001, pp. 634-637
Authors:
Ohno, J
Horio, Y
Sekido, Y
Hasegawa, Y
Takahashi, M
Nishizawa, J
Saito, H
Ishikawa, F
Shimokata, K
Citation: J. Ohno et al., Telomerase activation and p53 mutations in urethane-induced A/J mouse lungtumor development, CARCINOGENE, 22(5), 2001, pp. 751-756
Authors:
Takayama, F
Tsutsui, S
Horie, M
Shimokata, K
Niwa, T
Citation: F. Takayama et al., Glutathionyl hemoglobin in uremic patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis, KIDNEY INT, 59, 2001, pp. S155-S158
Authors:
Hashimoto, N
Kawabe, T
Hara, T
Imaizumi, K
Wakayama, H
Saito, H
Shimokata, K
Hasegawa, Y
Citation: N. Hashimoto et al., Effect of erythromycin on matrix metalloproteinase-9 and cell migration, J LA CL MED, 137(3), 2001, pp. 176-183
Authors:
Aoshima, T
Kajita, M
Sekido, Y
Kikuchi, S
Yasuda, I
Saheki, T
Watanabe, K
Shimokata, K
Niwa, T
Citation: T. Aoshima et al., Novel mutations (H337R and 238-362del) in the CPS1 gene cause carbamoyl phosphate synthetase I deficiency, HUMAN HERED, 52(2), 2001, pp. 99-101
Authors:
Ando, M
Minami, H
Ando, Y
Saka, H
Sakai, S
Yamamoto, M
Sasaki, Y
Shimokata, K
Hasegawa, Y
Citation: M. Ando et al., Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level, CLIN CANC R, 6(12), 2000, pp. 4733-4738
Authors:
Horio, Y
Hasegawa, Y
Sekido, Y
Takahashi, M
Roth, JA
Shimokata, K
Citation: Y. Horio et al., Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells, CANC GENE T, 7(4), 2000, pp. 537-544
Authors:
Hasegawa, Y
Nishiyama, Y
Imaizumi, K
Ono, N
Kinoshita, T
Hatano, S
Saito, H
Shimokata, K
Citation: Y. Hasegawa et al., Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy, CANC GENE T, 7(4), 2000, pp. 557-562
Authors:
Sato, M
Sekido, Y
Horio, Y
Takahashi, M
Saito, H
Minna, JD
Shimokata, K
Hasegawa, Y
Citation: M. Sato et al., Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer, JPN J CANC, 91(5), 2000, pp. 504-509
Authors:
Sugino, Y
Iinuma, Y
Ichiyama, S
Ito, Y
Ohkawa, S
Nakashima, N
Shimokata, K
Hasegawa, Y
Citation: Y. Sugino et al., In vivo development of decreased susceptibility to vancomycin in clinical isolates of methicillin-resistant Staphylococcus aureus, DIAG MICR I, 38(3), 2000, pp. 159-167
Authors:
Aoyama, I
Shimokata, K
Niwa, T
Citation: I. Aoyama et al., Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta(1) expression in spontaneously diabetic (OLETF) rats, AM J NEPHR, 20(3), 2000, pp. 232-241
Authors:
Wakayama, H
Hasegawa, Y
Kawabe, T
Hara, T
Matsuo, S
Mizuno, M
Takai, T
Kikutani, H
Shimokata, K
Citation: H. Wakayama et al., Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcR gamma-deficient mice, EUR J IMMUN, 30(4), 2000, pp. 1182-1190
Authors:
Aoshima, T
Sekido, Y
Miyazaki, T
Kajita, M
Mimura, S
Watanabe, K
Shimokata, K
Niwa, T
Citation: T. Aoshima et al., Rapid detection of deletion mutations in inherited metabolic diseases by melting curve analysis with LightCyler, CLIN CHEM, 46(1), 2000, pp. 119-122
Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity:A pharmacogenetic analysis
Authors:
Ando, Y
Saka, H
Ando, M
Sawa, T
Muro, K
Ueoka, H
Yokoyama, A
Saitoh, S
Shimokata, K
Hasegawa, Y
Citation: Y. Ando et al., Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity:A pharmacogenetic analysis, CANCER RES, 60(24), 2000, pp. 6921-6926
Authors:
Ando, Y
Tateishi, T
Sekido, Y
Yamamoto, T
Satoh, T
Hasegawa, Y
Kobayashi, S
Katsumata, Y
Shimokata, K
Saito, H
Citation: Y. Ando et al., Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4, J NAT CANC, 91(18), 1999, pp. 1587-1588
Authors:
Tsukushi, S
Shimokata, K
Niwa, T
Citation: S. Tsukushi et al., Gas chromatographic-mass spectrometric analysis of erythrocyte 3-deoxyglucosone in hemodialysis patients, J CHROMAT B, 731(1), 1999, pp. 37-44
Authors:
Matsumoto, K
Ogawa, N
Nerome, K
Numazaki, Y
Kawakami, Y
Shirato, K
Arakawa, M
Kudoh, S
Shimokata, K
Nakajima, S
Yamakido, M
Kashiwagi, S
Nagatake, T
Citation: K. Matsumoto et al., Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan, ANTIVIR TH, 4(2), 1999, pp. 61-68
Authors:
Ando, M
Minami, H
Ando, Y
Sakai, S
Shimono, Y
Sugiura, S
Saka, H
Shimokata, K
Hasegawa, Y
Citation: M. Ando et al., Pharmacological analysis of etoposide in elderly patients with lung cancer, CLIN CANC R, 5(7), 1999, pp. 1690-1695
Authors:
Imaizumi, K
Kawabe, T
Ichiyama, S
Kikutani, H
Yagita, H
Shimokata, K
Hasegawa, Y
Citation: K. Imaizumi et al., Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction, AM J P-LUNG, 21(1), 1999, pp. L49-L57
Authors:
Ando, M
Yamamoto, M
Kitagawa, C
Kumazawa, A
Sato, M
Shima, K
Watanabe, A
Shimokata, K
Hasegawa, Y
Citation: M. Ando et al., Autologous blood-patch pleurodesis for secondary spontaneous pneumothorax with persistent air leak, RESP MED, 93(6), 1999, pp. 432-434
Authors:
Ando, M
Ando, Y
Sugiura, S
Minami, H
Saka, H
Sakai, S
Shimokata, K
Hasegawa, Y
Citation: M. Ando et al., Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer, JPN J CANC, 90(2), 1999, pp. 249-253